LifeScience
Reduces the cost of gene therapies by using 3-10x less sample than other methodsi while generating faster results and more drug substance informatio...
August 03, 2023 | News
– Themed ‘Test. Link. Prioritize’, the Grant Program will Target Projects Focusing on Viral Hepatitis Elimination by 2030 &...
July 28, 2023 | News
Highlights: New AI leaderboard provides comparison of 25+ of the most important, representative and cutting-edge tasks across six distinct...
July 26, 2023 | News
Under the terms of the agreement, Biotheus will grant BioNTech worldwide, exclusive options to a preclinical-stage bispecific antibody and a clinical-stage...
July 20, 2023 | News
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Com...
July 19, 2023 | News
Polyplus is a leading provider of innovative technologies for cell and gene therapies. Transfection reagents developed and produced by Polyplus are key com...
July 18, 2023 | News
Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Ac...
July 18, 2023 | News
Under the terms of the agreement, Doer Bio will grant BioNTech a worldwide license to utilize one of Doer Bio's innovative discoveries to research, develop...
July 12, 2023 | News
With the inauguration of a new state-of-the-art cell therapy lab in early 2022, BeiGene is looking to broaden collaboration and expand ...
July 12, 2023 | News
Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult NK:IO’s platform, based on pionee...
July 11, 2023 | News
□ A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for t...
July 11, 2023 | News
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technolo...
July 11, 2023 | News
The VITA-FAST tokens, which allow holders to make decisions on IP licensing, set experiment priorities, and govern research on autophagy, have been met wit...
July 11, 2023 | News
Based in Waltham, MA, CorEvitas is a provider of real-world evidence, leveraging proprietary data to help pharmaceutical customers uncover clinical insight...
July 07, 2023 | News
Most Read
Bio Jobs
News